The common high-risk factors included poor differentiation (37.4%), elevated preoperative CEA (29.4%), pT4 tumor stage (17.6%), < 12 LNs (15.7%), and LVI (11.1%). The gene discussed is CEACAM5; the disease is neoplasm.